Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹20Cr
Rev Gr TTM
Revenue Growth TTM
2.23%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

ADVPETR-B
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -3.3 | -16.5 | -11.8 | -22.1 | 37.9 | 31.6 | 37.4 | 63.1 | 37.9 | -11.9 | -15.9 | -0.6 |
| 8 | 8 | 7 | 7 | 10 | 10 | 11 | 12 | 15 | 9 | 9 | 12 |
Operating Profit Operating ProfitCr |
| 1.9 | 1.0 | 9.7 | 4.5 | 5.5 | 3.6 | 0.8 | 2.8 | 4.3 | 4.4 | 2.9 | 1.3 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | -1,125.0 | -153.4 | -19.6 | -116.1 | 156.1 | 103.2 | -94.6 | 100.0 | 17.4 | 0.0 | -1,300.0 | |
| -5.1 | -3.8 | 4.5 | -0.6 | 2.1 | 0.1 | 0.2 | 0.0 | 1.8 | 0.1 | -2.5 | 0.0 |
| -4.6 | -3.5 | 4.1 | -0.5 | 2.6 | 0.1 | 0.2 | 0.0 | 3.0 | 0.1 | -2.6 | 0.0 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| -10.4 | -6.5 | -15.8 | 44.0 | 67.1 | -34.7 | 25.5 | 60.1 | 32.9 | -5.1 | 41.9 | -6.3 |
| 10 | 10 | 8 | 12 | 20 | 13 | 16 | 26 | 34 | 33 | 48 | 45 |
Operating Profit Operating ProfitCr |
| 6.9 | 7.9 | 10.0 | 6.6 | 4.6 | 6.5 | 6.8 | 5.2 | 7.4 | 5.2 | 3.0 | 3.3 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| -51.0 | 20.2 | 19.4 | -0.9 | 25.6 | -30.4 | 276.6 | 6.1 | 219.4 | -77.1 | 39.9 | -86.8 |
| 0.5 | 0.7 | 1.0 | 0.7 | 0.5 | 0.5 | 1.6 | 1.1 | 2.5 | 0.6 | 0.6 | 0.1 |
| 0.7 | 0.8 | 0.9 | 0.9 | 1.2 | 0.8 | 3.1 | 3.3 | 10.5 | 2.4 | 3.4 | 0.6 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 3 | 3 |
Current Liabilities Current LiabilitiesCr | 5 | 5 | 5 | 7 | 8 | 7 | 8 | 11 | 10 | 16 | 17 | 13 |
Non Current Liabilities Non Current LiabilitiesCr | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 5 | 6 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 6 | 6 | 6 | 8 | 9 | 8 | 9 | 11 | 10 | 16 | 17 | 14 |
Non Current Assets Non Current AssetsCr | 2 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 6 | 6 | 8 | 9 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 2 |
Investing Cash Flow Investing Cash FlowCr | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | -3 | -1 | -3 |
Financing Cash Flow Financing Cash FlowCr | 0 | -1 | 0 | 0 | -1 | -1 | 0 | -1 | -1 | 0 | 0 |
|
Free Cash Flow Free Cash FlowCr | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 0 |
| 1,525.3 | 1,325.9 | 806.2 | 799.7 | 1,148.0 | 1,488.5 | 273.3 | 607.7 | 354.2 | 509.8 | 696.7 |
CFO To EBITDA CFO To EBITDA% | 116.5 | 113.6 | 77.9 | 80.4 | 124.3 | 121.0 | 64.1 | 123.9 | 121.3 | 60.3 | 138.9 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 2 | 2 | 0 | 4 | 0 | 3 | 4 | 42 | 17 | 18 |
Price To Earnings Price To Earnings | 0.0 | 31.9 | 23.8 | 0.0 | 33.0 | 0.0 | 12.5 | 12.8 | 44.0 | 77.2 | 59.1 |
Price To Sales Price To Sales | 0.0 | 0.2 | 0.2 | 0.0 | 0.2 | 0.0 | 0.2 | 0.1 | 1.1 | 0.5 | 0.4 |
Price To Book Price To Book | 0.0 | 1.5 | 1.2 | 0.0 | 1.9 | 0.0 | 1.6 | 1.5 | 12.2 | 4.6 | 4.5 |
| 4.5 | 8.4 | 7.4 | 6.8 | 9.6 | 7.0 | 8.8 | 7.1 | 17.5 | 13.7 | 18.5 |
Profitability Ratios Profitability Ratios |
| 28.6 | 31.8 | 32.9 | 26.2 | 18.0 | 25.2 | 33.6 | 31.8 | 32.6 | 28.1 | 20.3 |
| 6.9 | 7.9 | 10.0 | 6.6 | 4.6 | 6.5 | 6.8 | 5.2 | 7.4 | 5.2 | 3.0 |
| 0.5 | 0.7 | 1.0 | 0.7 | 0.5 | 0.5 | 1.6 | 1.1 | 2.5 | 0.6 | 0.6 |
| 10.6 | 10.2 | 11.5 | 9.3 | 10.7 | 9.8 | 11.4 | 12.1 | 19.2 | 9.4 | 8.9 |
| 3.8 | 4.3 | 4.9 | 4.7 | 5.5 | 3.7 | 12.2 | 11.5 | 26.8 | 5.8 | 7.5 |
| 0.7 | 0.8 | 1.0 | 0.8 | 0.9 | 0.7 | 2.2 | 1.9 | 6.0 | 0.9 | 1.2 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
**Member of the Advance Group of Companies**
Advance Petrochemicals Limited (APL), established in **1984** and headquartered in Ahmedabad, Gujarat, is a specialized manufacturer of "green petrochemicals" and specialty chemical derivatives. The company is a key player in the Indian chemical industry—a sector that contributes approximately **7% to India’s GDP** and ranks as the **6th largest** producer globally. APL is listed on the **Bombay Stock Exchange (BSE)**.
---
### Specialized Product Portfolio and Industrial Applications
APL operates through a single primary business segment (Petroleum Products/Chemicals), focusing on high-performance derivatives of **Ethylene Oxide (EO)**, **Glycols**, and **Amines**.
* **Glycol Ethers (Methyl Cellosolve, Methyl Carbitol, Butyl Cellosolve):** High-performance solvents used in automotive paints and coatings to improve blush resistance and solubility. They also serve as essential solvents in the pharmaceutical and aviation sectors (as icing inhibitors).
* **Automotive Chemicals:** Production of **Hydraulic Brake Fluids** and **Anti-Freeze Radiator Coolants** for passenger and commercial vehicles.
* **Specialty Amines:** Including **Ethanol Amines** and **Alkyl Alkanolamines**, primarily utilized in refineries and oil exploration.
* **Surfactants and Polymers:** **Polyethylene Glycol (PEG)** and non-ionic surfactants used in detergents, personal care, and cosmetics as low-cost replacements for fatty acid isopropyl esters.
* **Industrial Binders:** Acrylic and Co-Acrylic binders for diverse manufacturing applications.
#### Production Performance (Comparative Volume)
| Product | FY 2022-2023 (Qty) | FY 2021-2022 (Qty) |
| :--- | :--- | :--- |
| **Methyl Cellosolve** | **826,315** | **837,836** |
| **Butyl Cellosolve** | **355,827** | **139,513** |
| **P.E.G. 4000** | **269,725** | **179,250** |
| **Methyl Carbitol** | **211,770** | **176,180** |
| **Brake Fluid** | **19,231** | **18,791** |
---
### Financial Performance and Capital Structure
The company demonstrated a robust recovery in **FY 2024-25**, rebounding from a slight contraction in the previous fiscal year. Growth is currently driven by "evergreen demand" from the automobile, refinery, and paint sectors.
#### Three-Year Financial Summary
| Metric (Rs. in Lakhs) | FY 2024-25 | FY 2023-24 | FY 2022-23 |
| :--- | :--- | :--- | :--- |
| **Total Revenue** | **5,034.51** | **3,524.68** | **3,718.00** |
| **Total Expenditure** | **4,987.00** | **3,493.40** | **3,623.57** |
| **Net Profit After Tax (PAT)** | **30.22** | **21.60** | **94.43** |
| **Reserves & Surplus** | **313.73** | **283.51** | **261.91** |
| **Dividend Recommended** | **Nil** | **Nil** | **Nil** |
* **Revenue Growth:** Achieved a **42.85%** increase in consolidated revenue in **FY25**.
* **Profitability:** PAT grew by **40%** year-on-year in **FY25**, though it remains below the **FY23** peak of **Rs. 94.43 Lacs**.
* **Equity Structure:** Paid-up equity share capital stands at **Rs. 90,00,000** (comprising **9,00,000** shares at **Rs. 10** face value).
* **Capital Allocation:** The company follows a conservative dividend policy, transferring **100%** of annual net profits to the **Statement of Profit & Loss** surplus to fund future operations.
---
### Strategic Growth Drivers and Market Positioning
APL is positioning itself to capture the rising demand in the **APAC automotive industry**, where **Glycol Ether-based solvents** are projected to grow at a **CAGR of nearly 5%**.
* **Capacity Expansion:** To meet surging volume requirements, the company recently increased surfactant manufacturing capacity by **780 Metric Tons Per Annum (MTPA)** and has formalized plans for further expansion in the **Glycol Ethers** segment.
* **Sectoral Tailwinds:**
* **Agro-Industries:** Demand for specialized chemical inputs has recently **doubled**, with a continued upward trend expected.
* **Cosmetics:** Urbanization and online beauty spending are driving the use of APL’s ethers as primary cosmetic solvents.
* **Aviation:** Continued demand for **Leing Inhibitors** in aviation fuel.
* **Leadership Stability:** **Mr. Pulkit Goenka** has been re-appointed as Managing Director for a **five-year term** (**October 2025 – October 2030**), with remuneration capped at **5% of net profits**.
---
### Operational Infrastructure and Governance
The company maintains centralized operations in Gujarat with a focus on quality and environmental compliance.
* **Manufacturing Plant:** Located at **Piplej, Ahmedabad**.
* **Certifications:** Holds **ISO 9001:2015** (Quality) and **ISO 14001:2015** (Environmental) certifications, alongside **UKAS Quality Management** accreditation.
* **Asset Management:** Maintains full particulars of **Property, Plant, and Equipment**; physical verification is conducted in a phased manner.
* **Investment Holdings:** APL holds **1,75,050** equity shares in **Advance Multitech Ltd** (cost: **Rs. 35,90,220**). Despite a current suspension of trading for these shares on the BSE, management maintains the fair value exceeds the cost.
---
### Risk Profile and Mitigation Strategies
APL operates in a high-barrier industry subject to global commodity cycles and stringent regulatory oversight.
#### Market and Macro Risks
* **Import Competition:** The Indian market for **Polyols** and **Propylene Glycol** is heavily impacted by low-cost imports. The announcement of **Anti-Dumping Duties (ADD)** in **March 2024** led to a pre-emptive surge in imports by competitors, causing temporary market oversupply.
* **External Volatility:** The **Russia-Ukraine conflict** and high global inflation have redirected cheaper chemical supplies into the Indian market, pressuring domestic margins.
* **Raw Material Costs:** Fluctuations in petrochemical intermediates and the logistical challenges of handling hazardous chemicals remain constant variables.
#### Compliance and Regulatory Risks
* **Promoter Dematerialization:** As of **September 2024**, only **7.61%** of promoter holdings are in **demat form**, which is significantly below the **SEBI-mandated 100%**.
* **Financial Reconciliations:** Financial notes indicate that balances for **unsecured loans, debtors, and creditors** are subject to third-party confirmation.
* **Environmental Shift:** Increasing pressure to adopt **circular economy** principles and **green chemistry** requires ongoing R&D investment.
#### Mitigation Framework
The company has established a **Risk Management Committee** to prioritize high-impact risks. Growth is supported by national initiatives such as **Make in India** and the **Production-Linked Incentive (PLI)** schemes, which aim to reduce the trade deficit in specialty chemicals.